Platelet-derived extracellular vesicles play an important role in platelet transfusion therapy

References

• Prodger CF, Rampotas A, Estcourt LJ, Stanworth SJ, Murphy MF. Platelet transfusion: alloimmunization and refractoriness. Semin Hematol. 2020;57(2):92–11. doi:10.1053/j.seminhematol.2019.10.001.
   PubMed Web of Science ®Google Scholar
• Ng MSY, Tung JP, Fraser JF. Platelet storage lesions: what more do we know now? Transfus Med Rev. 2018;S0887-7963(17)30189–X. doi:10.1016/j.tmrv.2018.04.001.
   Web of Science ®Google Scholar
• Tissot JD, Bardyn M, Sonego G, Abonnenc M, Prudent M. The storage lesions: from past to future. Transfus Clin Biol. 2017;24(3):277–84. doi:10.1016/j.tracli.2017.05.012.
   PubMed Web of Science ®Google Scholar
• Hosseini E, Ghasemzadeh M, Nassaji F, Jamaat ZP. GPVI modulation during platelet activation and storage: its expression levels and ectodomain shedding compared to markers of platelet storage lesion. Platelets. 2017;28(5):498–508. doi:10.1080/09537104.2016.1235692.
   PubMed Web of Science ®Google Scholar
• Sut C, Tariket S, Aubron C, Aloui C, Hamzeh-Cognasse H, Berthelot P, Laradi S, Greinacher A, Garraud O, Cognasse F. The non-hemostatic aspects of transfused platelets. Front Med. 2018;5:42. doi:10.3389/fmed.2018.00042.
   Web of Science ®Google Scholar
• Valkonen S, Holopainen M, Colas RA, Impola U, Dalli J, Käkelä R, Siljander PR, Laitinen S. Lipid mediators in platelet concentrate and extracellular vesicles: molecular mechanisms from membrane glycerophospholipids to bioactive molecules. Biochim Biophys Acta Mol Cell Biol Lipids. 2019;1864(8):1168–82. doi:10.1016/j.bbalip.2019.03.011.
   PubMed Web of Science ®Google Scholar
• Marcoux G, Magron A, Sut C, Laroche A, Laradi S, Hamzeh-Cognasse H, Allaeys I, Cabon O, Julien AS, Garraud O, et al. Platelet-derived extracellular vesicles convey mitochondrial DAMPs in platelet concentrates and their levels are associated with adverse reactions. Transfusion. 2019;59(7):2403–14. doi:10.1111/trf.15300.
   PubMed Web of Science ®Google Scholar
• Green SM, Padula MP, Marks DC, Johnson L. The lipid composition of platelets and the impact of storage: an overview. Transfus Med Rev. 2020 Apr;34(2):108–16. doi:10.1016/j.tmrv.2019.12.001.
   PubMed Web of Science ®Google Scholar
• Cocozza F, Grisard E, Martin-Jaular L, Mathieu M, Théry C. SnapShot: extracellular vesicles. Cell. 2020;182(1):262–262.e1. doi:10.1016/j.cell.2020.04.054.
   PubMed Web of Science ®Google Scholar
• Lopez E, Srivastava AK, Burchfield J, Wang YW, Cardenas JC, Togarrati PP, Miyazawa B, Gonzalez E, Holcomb JB, Pati S, et al. Platelet-derived- extracellular vesicles promote hemostasis and prevent the development of hemorrhagic shock. Sci Rep. 2019;9(1):17676. doi:10.1038/s41598-019-53724-y.
   PubMedGoogle Scholar
• Melki I, Tessandier N, Zufferey A, Boilard E. Platelet microvesicles in health and disease. Platelets. 2017;28(3):214–21. doi:10.1080/09537104.2016.1265924.
   PubMed Web of Science ®Google Scholar
• Garraud O, Cognasse F. Are platelets cells? And if yes, are they immune cells? Front Immunol. 2015;6:70. doi:10.3389/fimmu.2015.00070.
   PubMed Web of Science ®Google Scholar
• Wood B, Padula MP, Marks DC, Johnson L. The immune potential of ex vivo stored platelets: a review. Vox Sang. 2021;116(5):477–88. doi:10.1111/vox.13058.
   PubMed Web of Science ®Google Scholar
• Cognasse F, Duchez AC, Audoux E, Ebermeyer T, Arthaud CA, Prier A, Eyraud MA, Mismetti P, Garraud O, Bertoletti L, et al. Platelets as key factors in inflammation: focus on CD40L/CD40. Front Immunol. 2022;13:825892. doi:10.3389/fimmu.2022.825892.
   PubMed Web of Science ®Google Scholar
• Sprague DL, Elzey BD, Crist SA, Waldschmidt TJ, Jensen RJ, Ratliff TL. Platelet-mediated modulation of adaptive immunity: unique delivery of CD154 signal by platelet-derived membrane vesicles. Blood. 2008;111(10):5028–36. doi:10.1182/blood-2007-06-097410.
   PubMed Web of Science ®Google Scholar
• Tariket S, Hamzeh-Cognasse H, Laradi S, Arthaud C-A, Eyraud M-A, Bourlet T, Berthelot P, Garraud O, Cognasse F. Evidence of CD40L/CD40 pathway involvement in experimental transfusion-related acute lung injury. Sci Rep. 2019;9(1):12536. doi:10.1038/s41598-019-49040-0.
   PubMedGoogle Scholar
• McFadyen JD, Kaplan ZS. Platelets are not just for clots. Transfus Med Rev. 2015;29(2):110–19. doi:10.1016/j.tmrv.2014.11.006.
   PubMed Web of Science ®Google Scholar
• Krauel K, Pötschke C, Weber C, Kessler W, Fürll B, Ittermann T, Maier S, Hammerschmidt S, Bröker BM, Greinacher A. Platelet factor 4 binds to bacteria, [corrected] inducing antibodies cross-reacting with the major antigen in heparin-induced thrombocytopenia. Blood. 2011;117(4):1370–8. doi:10.1182/blood-2010-08-301424.
   PubMed Web of Science ®Google Scholar
• Koupenova M, Mick E, Mikhalev E, Benjamin EJ, Tanriverdi K, Freedman JE. Sex differences in platelet toll-like receptors and their association with cardiovascular risk factors. Arterioscler Thromb Vasc Biol. 2015;35(4):1030–7. doi:10.1161/ATVBAHA.114.304954.
   PubMed Web of Science ®Google Scholar
• Vogel S, Bodenstein R, Chen Q, Feil S, Feil R, Rheinlaender J, Schäffer TE, Bohn E, Frick JS, Borst O, et al. Platelet-derived HMGB1 is a critical mediator of thrombosis. J Clin Invest. 2015;125(12):4638–54. doi:10.1172/JCI81660.
   PubMed Web of Science ®Google Scholar
• Nguyen TH, Medvedev N, Delcea M, Greinacher A. Anti-platelet factor 4/polyanion antibodies mediate a new mechanism of autoimmunity. Nat Commun. 2017;8(1):14945. doi:10.1038/ncomms14945.
   PubMedGoogle Scholar
• Palankar R, Kohler TP, Krauel K, Wesche J, Hammerschmidt S, Greinacher A. Platelets kill bacteria by bridging innate and adaptive immunity via platelet factor 4 and FcγRIIA. J Thromb Haemost. 2018;16(6):1187–97. doi:10.1111/jth.13955.
   PubMed Web of Science ®Google Scholar
• Wang J, Zhou P, Han Y, Zhang H. Platelet transfusion for cancer secondary thrombocytopenia: platelet and cancer cell interaction. Transl Oncol. 2021;14(4):101022. doi:10.1016/j.tranon.2021.101022.
   PubMed Web of Science ®Google Scholar
• Kreuger AL, Caram-Deelder C, Jacobse J, Kerkhoffs JL, van der Bom JG, Middelburg RA. Effect of storage time of platelet products on clinical outcomes after transfusion: a systematic review and meta-analyses. Vox Sang. 2017;112(4):291–300. doi:10.1111/vox.12494.
   PubMed Web of Science ®Google Scholar
• Greening DW, Simpson RJ, Sparrow RL. Preparation of platelet concentrates for research and transfusion purposes. Methods Mol Biol. 2017;1619:31–42. doi:10.1007/978-1-4939-7057-5_3.
   PubMedGoogle Scholar
• Egidi MG, D’Alessandro A, Mandarello G, Zolla L. Troubleshooting in platelet storage temperature and new perspectives through proteomics. Blood Transfus. 2010;8(Suppl 3):s73–s81. doi:10.2450/2010.012S.
   PubMedGoogle Scholar
• Pienimaeki-Roemer A, Ruebsaamen K, Boettcher A, Orsó E, Scherer M, Liebisch G, Kilalic D, Ahrens N, Schmitz G. Stored platelets alter glycerophospholipid and sphingolipid species, which are differentially transferred to newly released extracellular vesicles. Transfusion. 2013;53(3):612–26. doi:10.1111/j.1537-2995.2012.03775.x.
   PubMed Web of Science ®Google Scholar
• Zhao XM, Wang Y, Yu Y, Jiang H, Babinska A, Chen XY, He KG, Min XD, Han JJ, Yang CX, et al. Plasma phospholipid transfer protein promotes platelet aggregation. Thromb Haemost. 2018;118(12):2086–97. doi:10.1055/s-0038-1675228.
   PubMed Web of Science ®Google Scholar
• Żmigrodzka M, Witkowska-Piłaszewicz O, Winnicka A. Platelets extracellular vesicles as regulators of cancer progression-an updated perspective. Int J Mol Sci. 2020;21(15):5195. doi:10.3390/ijms21155195.
   PubMed Web of Science ®Google Scholar
• Chu Y, Guo H, Zhang Y, Qiao R. Procoagulant platelets: generation, characteristics, and therapeutic target. J Clin Lab Anal. 2021;35(5):e23750. doi:10.1002/jcla.23750.
   PubMed Web of Science ®Google Scholar
• Ghasemzadeh M, Hosseini E, Roudsari ZO, Zadkhak P. Intraplatelet reactive oxygen species (ROS) correlate with the shedding of adhesive receptors, microvesiculation and platelet adhesion to collagen during storage: does endogenous ROS generation downregulate platelet adhesive function? Thromb Res. 2018;163:153–61. doi:10.1016/j.thromres.2018.01.048.
   PubMed Web of Science ®Google Scholar
• van Niel G, D’Angelo G, Raposo G. Shedding light on the cell biology of extracellular vesicles. Nat Rev Mol Cell Biol. 2018;19(4):213–28. doi:10.1038/nrm.2017.125.
   PubMed Web of Science ®Google Scholar
• Heinzmann ACA, Karel MFA, Coenen DM, Vajen T, Meulendijks NMM, Nagy M, Suylen DPL, Cosemans JMEM, Heemskerk JWM, Hackeng TM, et al. Complementary roles of platelet αIIbβ3 integrin, phosphatidylserine exposure and cytoskeletal rearrangement in the release of extracellular vesicles. Atherosclerosis. 2020;310:17–25. doi:10.1016/j.atherosclerosis.2020.07.015.
   PubMed Web of Science ®Google Scholar
• van der Meer PF, de Korte D. Platelet additive solutions: a review of the latest developments and their clinical implications. Transfus Med Hemother. 2018;45(2):98–102. doi:10.1159/000487513.
   PubMed Web of Science ®Google Scholar
• Maurer-Spurej E, Larsen R, Labrie A, Heaton A, Chipperfield K. Microparticle content of platelet concentrates is predicted by donor microparticles and is altered by production methods and stress. Transfus Apher Sci. 2016;55(1):35–43. doi:10.1016/j.transci.2016.07.010.
   PubMed Web of Science ®Google Scholar
• Capraru A, Jalowiec KA, Medri C, Daskalakis M, Zeerleder SS, Mansouri Taleghani B. Platelet transfusion-insights from current practice to future development. J Clin Med. 2021;10(9):1990. Published 2021 May 6. doi:10.3390/jcm10091990.
   PubMed Web of Science ®Google Scholar
• van Hout FMA, Middelburg RA, van der Meer PF, Pors A, Wiersum-Osselton JC, Schipperus MR, Kerkhoffs JL, van der Bom JG. Effect of storage of platelet concentrates in PAS-B, PAS-C, or plasma on transfusion reactions. Transfusion. 2019;59(10):3140–5. doi:10.1111/trf.15497.
   PubMed Web of Science ®Google Scholar
• Valkonen S, Mallas B, Impola U, Valkeajärvi A, Eronen J, Javela K, Siljander P-M, Laitinen S. Assessment of time-dependent platelet activation using extracellular vesicles, CD62P exposure, and soluble glycoprotein V content of platelet concentrates with two different platelet additive solutions. Transfus Med Hemother. 2019;46(4):267–75. doi:10.1159/000499958.
   PubMed Web of Science ®Google Scholar
• Waters L, Cameron M, Padula MP, Marks DC, Johnson L. Refrigeration, cryopreservation and pathogen inactivation: an updated perspective on platelet storage conditions. Vox Sang. 2018;113(4):317–28. doi:10.1111/vox.12640.
   PubMed Web of Science ®Google Scholar
• Magron A, Laugier J, Provost P, Boilard E. Pathogen reduction technologies: the pros and cons for platelet transfusion. Platelets. 2018;29(1):2–8. doi:10.1080/09537104.2017.1306046.
   PubMed Web of Science ®Google Scholar
• Osman A, Hitzler WE, Provost P. The platelets’ perspective to pathogen reduction technologies. Platelets. 2018;29(2):140–7. doi:10.1080/09537104.2017.1293806.
   PubMed Web of Science ®Google Scholar
• Marschner S, Goodrich R. Pathogen reduction technology treatment of platelets, plasma and whole blood using riboflavin and UV light. Transfus Med Hemother. 2011;38(1):8–18. doi:10.1159/000324160.
   PubMed Web of Science ®Google Scholar
• Seghatchian J, Amiral J. Unresolved clinical aspects and safety hazards of blood derived- EV/MV in stored blood components: from personal memory lanes to newer perspectives on the roles of EV/MV in various biological phenomena. Transfus Apher Sci. 2016;55(1):10–22. doi:10.1016/j.transci.2016.07.007.
   PubMed Web of Science ®Google Scholar
• Diallo I, Benmoussa A, Laugier J, Osman A, Hitzler WE, Provost P. Platelet pathogen reduction technologies alter the microRNA profile of platelet-derived microparticles. Front Cardiovasc Med. 2020;7:31. doi:10.3389/fcvm.2020.00031.
   PubMed Web of Science ®Google Scholar
• Bohonek M, Kutac D, Landova L, Koranova M, Sladkova E, Staskova E, Voldrich M, Tyll T. The use of cryopreserved platelets in the treatment of polytraumatic patients and patients with massive bleeding. Transfusion. 2019;59(S2):1474–8. doi:10.1111/trf.15177.
   PubMedGoogle Scholar
• Johnson L, Tan S, Wood B, Davis A, Marks DC. Refrigeration and cryopreservation of platelets differentially affect platelet metabolism and function: a comparison with conventional platelet storage conditions. Transfusion. 2016;56(7):1807–18. doi:10.1111/trf.13630.
   PubMed Web of Science ®Google Scholar
• Johnson L, Tan S, Jenkins E, Wood B, Marks DC. Characterization of biologic response modifiers in the supernatant of conventional, refrigerated, and cryopreserved platelets. Transfusion. 2018;58(4):927–37. doi:10.1111/trf.14475.
   PubMed Web of Science ®Google Scholar
• Johnson L, Coorey CP, Marks DC. The hemostatic activity of cryopreserved platelets is mediated by phosphatidylserine-expressing platelets and platelet microparticles. Transfusion. 2014;54(8):1917–26. doi:10.1111/trf.12578.
   PubMed Web of Science ®Google Scholar
• Raynel S, Padula MP, Marks DC, Johnson L. Cryopreservation alters the membrane and cytoskeletal protein profile of platelet microparticles. Transfusion. 2015;55(10):2422–32. doi:10.1111/trf.13165.
   PubMed Web of Science ®Google Scholar
• Getz TM, Montgomery RK, Bynum JA, Aden JK, Pidcoke HF, Cap AP. Storage of platelets at 4°C in platelet additive solutions prevents aggregate formation and preserves platelet functional responses. Transfusion. 2016;56(6):1320–8. doi:10.1111/trf.13511.
   PubMed Web of Science ®Google Scholar
• Hermida-Nogueira L, García Á. Extracellular vesicles in the transfusion medicine field: The potential of proteomics. Proteomics. 2021;21(13–14):e2000089. doi:10.1002/pmic.202000089.
   PubMed Web of Science ®Google Scholar
• Xu Y, Feng K, Zhao H, Di L, Wang L, Wang R. Tumor-derived extracellular vesicles as messengers of natural products in cancer treatment. Theranostics. 2022;12(4):1683–714. Published 2022 Jan 16. doi:10.7150/thno.67775.
   PubMed Web of Science ®Google Scholar
• Tkach M, Théry C. Communication by extracellular vesicles: where we are and where we need to go. Cell. 2016;164(6):1226–32. doi:10.1016/j.cell.2016.01.043.
   PubMed Web of Science ®Google Scholar
• Hernández A, Arab JP, Reyes D, Lapitz A, Moshage H, Bañales JM, Arrese M. Extracellular vesicles in NAFLD/ALD: from pathobiology to therapy. Cells. 2020;9(4):817. doi:10.3390/cells9040817.
   PubMed Web of Science ®Google Scholar
• Brahmer A, Neuberger E, Esch-Heisser L, Haller N, Jorgensen MM, Baek R, Möbius W, Simon P, Krämer-Albers EM. Platelets, endothelial cells and leukocytes contribute to the exercise-triggered release of extracellular vesicles into the circulation. J Extracell Vesicles. 2019;8(1):1615820. doi:10.1080/20013078.2019.1615820.
   PubMed Web of Science ®Google Scholar
• Liu L, Deng QJ. Role of platelet-derived extracellular vesicles in traumatic brain injury-induced coagulopathy and inflammation. Neural Regen Res. 2022;17(10):2102–7. doi:10.4103/1673-5374.335825.
   PubMed Web of Science ®Google Scholar
• Malenica M, Vukomanović M, Kurtjak M, Masciotti V, Dal Zilio S, Greco S, Lazzarino M, Krušić V, Perčić M, Jelovica Badovinac I, et al. Perspectives of microscopy methods for morphology characterisation of extracellular vesicles from human biofluids. Biomedicines. 2021;9(6):603. doi:10.3390/biomedicines9060603.
   PubMed Web of Science ®Google Scholar
• Ferreira PM, Bozbas E, Tannetta SD, Alroqaiba N, Zhou R, Crawley JTB, Gibbins JM, Jones CI, Ahnström J, Yaqoob P. Mode of induction of platelet-derived extracellular vesicles is a critical determinant of their phenotype and function. Sci Rep. 2020;10(1):18061. doi:10.1038/s41598-020-73005-3.
   PubMed Web of Science ®Google Scholar
• De Paoli SH, Tegegn TZ, Elhelu OK, Strader MB, Patel M, Diduch LL, Tarandovskiy ID, Wu Y, Zheng J, Ovanesov MV, et al. Dissecting the biochemical architecture and morphological release pathways of the human platelet extracellular vesiculome. Cell Mol Life Sci. 2018;75(20):3781–801. doi:10.1007/s00018-018-2771-6.
   PubMed Web of Science ®Google Scholar
• Lamparski HG, Metha-Damani A, Yao JY, Patel S, Hsu DH, Ruegg C, Le Pecq JB. Production and characterization of clinical grade exosomes derived from dendritic cells. J Immunol Methods. 2002;270(2):211–26. doi:10.1016/s0022-1759(02)00330-7.
   PubMed Web of Science ®Google Scholar
• Nordin JZ, Lee Y, Vader P, Mäger I, Johansson HJ, Heusermann W, Wiklander OP, Hällbrink M, Seow Y, Bultema JJ, et al. Ultrafiltration with size-exclusion liquid chromatography for high yield isolation of extracellular vesicles preserving intact biophysical and functional properties. Nanomedicine. 2015;11(4):879–83. doi:10.1016/j.nano.2015.01.003.
   PubMed Web of Science ®Google Scholar
• Tiwari S, Kumar V, Randhawa S, Verma SK. Preparation and characterization of extracellular vesicles. Am J Reprod Immunol. 2021;85(2):e13367. doi:10.1111/aji.13367.
   PubMed Web of Science ®Google Scholar
• Shao H, Im H, Castro CM, Breakefield X, Weissleder R, Lee H. New technologies for analysis of extracellular vesicles. Chem Rev. 2018;118(4):1917–50. doi:10.1021/acs.chemrev.7b00534.
   PubMed Web of Science ®Google Scholar
• Shan C, Liang Y, Cai H, Wang F, Chen X, Yin Q, Wang K, Wang Y. Emerging function and clinical significance of extracellular vesicle noncoding RNAs in lung cancer. Mol Ther Oncolytics. 2022;24:814–33. doi:10.1016/j.omto.2022.02.016.
   PubMed Web of Science ®Google Scholar
• Daurat A, Roger C, Gris J, Daurat G, Feissel M, Le Manach Y, Lefrant J, Muller L. Apheresis platelets are more frequently associated with adverse reactions than pooled platelets both in recipients and in donors: a study from French hemovigilance data. Transfusion. 2016;56(6):1295–303. doi:10.1111/trf.13475.
   PubMed Web of Science ®Google Scholar
• Vogel R, Savage J, Muzard J, Camera GD, Vella G, Law A, Marchioni M, Mehn D, Geiss O, Peacock B, et al. Measuring particle concentration of multimodal synthetic reference materials and extracellular vesicles with orthogonal techniques: who is up to the challenge? J Extracell Vesicles. 2021;10(3):e12052. doi:10.1002/jev2.12052.
   PubMed Web of Science ®Google Scholar
• Martin N, Tu X, Egan AJ, Stover C. Complement activation on endothelial cell-derived microparticles-a key determinant for cardiovascular risk in patients with systemic lupus erythematosus? Medicina (Kaunas). 2020;56(10):533. doi:10.3390/medicina56100533.
   PubMed Web of Science ®Google Scholar
• Fedorov A, Kondratov K, Kishenko V, Mikhailovskii V, Kudryavtsev I, Belyakova M, Sidorkevich S, Vavilova T, Kostareva A, Sirotkina O, et al. Application of high-sensitivity flow cytometry in combination with low-voltage scanning electron microscopy for characterization of nanosized objects during platelet concentrate storage. Platelets. 2020;31(2):226–35. doi:10.1080/09537104.2019.1599337.
   PubMed Web of Science ®Google Scholar
• Vogel R, Pal AK, Jambhrunkar S, Patel P, Thakur SS, Reátegui E, Parekh HS, Saá P, Stassinopoulos A, Broom MF. High-resolution single particle zeta potential characterisation of biological nanoparticles using tunable resistive pulse sensing. Sci Rep. 2017;7(1):17479. doi:10.1038/s41598-017-14981-x.
   PubMedGoogle Scholar
• Roberts GS, Kozak D, Anderson W, Broom MF, Vogel R, Trau M. Tunable nano/micropores for particle detection and discrimination: scanning ion occlusion spectroscopy. Small. 2010;6(23):2653–8. doi:10.1002/smll.201001129.
   PubMed Web of Science ®Google Scholar
• Kurtjak M, Kereïche S, Klepac D, Križan H, Perčić M, Krušić Alić V, Lavrin T, Lenassi M, Wechtersbach K, Kojc N, et al. Unveiling the native morphology of extracellular vesicles from human cerebrospinal fluid by atomic force and cryogenic electron microscopy. Biomedicines. 2022;10(6):1251. doi:10.3390/biomedicines10061251.
   PubMed Web of Science ®Google Scholar
• Antwi-Baffour S, Adjei J, Aryeh C, Kyeremeh R, Kyei F, Seidu MA. Understanding the biosynthesis of platelets-derived extracellular vesicles. Immun Inflamm Dis. 2015;3(3):133–40. doi:10.1002/iid3.66.
   PubMed Web of Science ®Google Scholar
• Théry C, Witwer KW, Aikawa E, Alcaraz MJ, Anderson JD, Andriantsitohaina R, Antoniou A, Arab T, Archer F, Atkin-Smith GK, et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the international society for extracellular vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles. 2018;7(1):1535750. doi:10.1080/20013078.2018.1535750.
   PubMed Web of Science ®Google Scholar
• Freitas D, Balmaña M, Poças J, Campos D, Osório H, Konstantinidi A, Vakhrushev SY, Magalhães A, Reis CA. Different isolation approaches lead to diverse glycosylated extracellular vesicle populations. J Extracell Vesicles. 2019;8(1):1621131. doi:10.1080/20013078.2019.1621131.
   PubMed Web of Science ®Google Scholar
• Ekström K, Crescitelli R, Pétursson HI, Johansson J, Lässer C, Olofsson Bagge R. Characterization of surface markers on extracellular vesicles isolated from lymphatic exudate from patients with breast cancer. BMC Cancer. 2022;22(1):50. doi:10.1186/s12885-021-08870-w.
   PubMed Web of Science ®Google Scholar
• Sobolewska A, Włodarczyk M, Stec-Michalska K, Fichna J, Wiśniewska-Jarosińska M. Mean platelet volume in crohn’s disease patients predicts sustained response to a 52-week infliximab therapy: a pilot study. Dig Dis Sci. 2016;61(2):542–9. doi:10.1007/s10620-015-3894-3.
   PubMed Web of Science ®Google Scholar
• Heijnen HF, Schiel AE, Fijnheer R, Geuze HJ, Sixma JJ. Activated platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules. Blood. 1999;94(11):3791–9. doi:10.1182/blood.V94.11.3791.
   PubMed Web of Science ®Google Scholar
• Dean WL, Lee MJ, Cummins TD, Schultz DJ, Powell DW. Proteomic and functional characterisation of platelet microparticle size classes. Thromb Haemost. 2009;102(4):711–8. doi:10.1160/TH09-04-243.
   PubMed Web of Science ®Google Scholar
• Marcoux G, Laroche A, Hasse S, Bellio M, Mbarik M, Tamagne M, Allaeys I, Zufferey A, Lévesque T, Rebetz J, et al. Platelet EVs contain an active proteasome involved in protein processing for antigen presentation via MHC-I molecules. Blood. 2021;138(25):2607–20. doi:10.1182/blood.2020009957.
   PubMed Web of Science ®Google Scholar
• Guo SC, Tao SC, Yin WJ, Qi X, Yuan T, Zhang CQ. Exosomes derived from platelet-rich plasma promote the re-epithelization of chronic cutaneous wounds via activation of YAP in a diabetic rat model. Theranostics. 2017;7(1):81–96. Published 2017 Jan 1. doi:10.7150/thno.16803.
   PubMed Web of Science ®Google Scholar
• Intini G, Andreana S, Intini FE, Buhite RJ, Bobek LA. Calcium sulfate and platelet-rich plasma make a novel osteoinductive biomaterial for bone regeneration. J Transl Med. 2007;5(1):13. doi:10.1186/1479-5876-5-13.
   PubMedGoogle Scholar
• Spakova T, Janockova J, Rosocha J. Characterization and therapeutic use of extracellular vesicles derived from platelets. Int J Mol Sci. 2021;22(18):9701. doi:10.3390/ijms22189701.
   PubMed Web of Science ®Google Scholar
• Jain A, Marwaha N, Sharma RR, Kaur J, Thakur M, Dhawan HK. Serial changes in morphology and biochemical markers in platelet preparations with storage. Asian J Transfus Sci. 2015;9(1):41–7. doi:10.4103/0973-6247.150949.
   PubMedGoogle Scholar
• Black A, Pienimaeki-Roemer A, Kenyon O, Orsó E, Schmitz G. Platelet-derived extracellular vesicles in plateletpheresis concentrates as a quality control approach. Transfusion. 2015;55(9):2184–96. doi:10.1111/trf.13128.
   PubMed Web of Science ®Google Scholar
• Price J, Gardiner C, Harrison P. Platelet-enhanced plasma: Characterization of a novel candidate resuscitation fluid’s extracellular vesicle content, clotting parameters, and thrombin generation capacity. Transfusion. 2021;61(7):2179–94. doi:10.1111/trf.16423.
   PubMed Web of Science ®Google Scholar
• Frank J, Richter M, de Rossi C, Lehr CM, Fuhrmann K, Fuhrmann G. Extracellular vesicles protect glucuronidase model enzymes during freeze-drying. Sci Rep. 2018;8(1):12377. doi:10.1038/s41598-018-30786-y.
   PubMedGoogle Scholar
• Chatterjee V, Yang X, Ma Y, Wu MH, Yuan SY. Extracellular vesicles: new players in regulating vascular barrier function. Am J Physiol Heart Circ Physiol. 2020;319(6):H1181–H96. doi:10.1152/ajpheart.00579.2020.
   PubMed Web of Science ®Google Scholar
• Zubairova LD, Nabiullina RM, Nagaswami C, Zuev YF, Mustafin IG, Litvinov RI, Weisel JW. Circulating microparticles alter formation, structure, and properties of fibrin clots. Sci Rep. 2015;5(1):17611. doi:10.1038/srep17611.
   PubMedGoogle Scholar
• Sinauridze EI, Kireev DA, Popenko NY, Pichugin AV, Panteleev MA, Krymskaya OV, Ataullakhanov FI. Platelet microparticle membranes have 50- to 100-fold higher specific procoagulant activity than activated platelets. Thromb Haemost. 2007;97(3):425–34. doi:10.1160/th06-06-0313.
   PubMed Web of Science ®Google Scholar
• Ceroi A, Delettre FA, Marotel C, Gauthier T, Asgarova A, Biichlé S, Duperrier A, Mourey G, Perruche S, Lagrost L, et al. The anti-inflammatory effects of platelet-derived microparticles in human plasmacytoid dendritic cells involve liver X receptor activation. Haematologica. 2016;101(3):e72–e6. doi:10.3324/haematol.2015.135459.
   PubMed Web of Science ®Google Scholar
• Johnson J, Wu YW, Blyth C, Lichtfuss G, Goubran H, Burnouf T. Prospective therapeutic applications of platelet extracellular vesicles. Trends Biotechnol. 2021;39(6):598–612. doi:10.1016/j.tibtech.2020.10.004.
   PubMed Web of Science ®Google Scholar
• Puhm F, Boilard E, Machlus KR. Platelet extracellular vesicles: beyond the blood. Arterioscler Thromb Vasc Biol. 2021;41(1):87–96. doi:10.1161/ATVBAHA.120.314644.
   PubMed Web of Science ®Google Scholar
• Yasui K, Matsuyama N, Kuroishi A, Tani Y, Furuta RA, Hirayama F. Mitochondrial damage-associated molecular patterns as potential proinflammatory mediators in post-platelet transfusion adverse effects. Transfusion. 2016;56(5):1201–12. doi:10.1111/trf.13535.
   PubMed Web of Science ®Google Scholar
• Fletcher CH, DomBourian MG, Millward PA. Platelet transfusion for patients with cancer. Cancer Control. 2015;22(1):47–51. doi:10.1177/107327481502200107.
   PubMed Web of Science ®Google Scholar
• Stanworth SJ, Hudson CL, Estcourt LJ, Johnson RJ, Wood EM. TOPPS study investigators. Risk of bleeding and use of platelet transfusions in patients with hematologic malignancies: recurrent event analysis. Haematologica. 2015;100(6):740–7. doi:10.3324/haematol.2014.118075.
   PubMed Web of Science ®Google Scholar
• Anene C, Graham AM, Boyne J, Roberts W. Platelet microparticle delivered microRNA-Let-7a promotes the angiogenic switch. Biochim Biophys Acta Mol Basis Dis. 2018;1864(8):2633–43. doi:10.1016/j.bbadis.2018.04.013.
   PubMed Web of Science ®Google Scholar
• Goubran H, Sabry W, Kotb R, Seghatchian J, Burnouf T. Platelet microparticles and cancer: an intimate cross-talk. Transfus Apher Sci. 2015;53(2):168–72. doi:10.1016/j.transci.2015.10.014.
   PubMed Web of Science ®Google Scholar
• Sadallah S, Schmied L, Eken C, Charoudeh HN, Amicarella F, Schifferli JA. Platelet-derived ectosomes reduce NK cell function. J Immunol. 2016;197(5):1663–71. doi:10.4049/jimmunol.1502658.
   PubMed Web of Science ®Google Scholar
• Park M, Kang KW. Phosphatidylserine receptor-targeting therapies for the treatment of cancer. Arch Pharm Res. 2019;42(7):617–28. doi:10.1007/s12272-019-01167-4.
   PubMed Web of Science ®Google Scholar
• Labelle M, Begum S, Hynes RO. Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis. Cancer Cell. 2011;20(5):576–90. doi:10.1016/j.ccr.2011.09.009.
   PubMed Web of Science ®Google Scholar
• Janowska-Wieczorek A, Wysoczynski M, Kijowski J, Marquez-Curtis L, Machalinski B, Ratajczak J, Ratajczak MZ. Microvesicles derived from activated platelets induce metastasis and angiogenesis in lung cancer. Int J Cancer. 2005;113(5):752–60. doi:10.1002/ijc.20657.
   PubMed Web of Science ®Google Scholar
• Tao SC, Guo SC, Zhang CQ. Platelet-derived extracellular vesicles: an emerging therapeutic approach. Int J Biol Sci. 2017;13(7):828–34. doi:10.7150/ijbs.19776.
   PubMed Web of Science ®Google Scholar
• Reesink HW, Lee J, Keller A, Dennington P, Pink J, Holdsworth R, Schennach H, Goldman M, Petraszko T, Sun J, et al. Measures to prevent transfusion-related acute lung injury (TRALI). Vox Sang. 2012;103(3):231–59. doi:10.1111/j.1423-0410.2012.01596.x.
   PubMed Web of Science ®Google Scholar
• Wagner T, Vetter A, Dimovic N, Guber SE, Helmberg W, Kröll W, Lanzer G, Mayr WR, Neumüller J. Ultrastructural changes and activation differences in platelet concentrates stored in plasma and additive solution. Transfusion. 2002;42(6):719–27. doi:10.1046/j.1537-2995.2002.00125.x.
   PubMed Web of Science ®Google Scholar
• Mowla SJ, Kracalik IT, Sapiano MRP, O’Hearn L, Andrzejewski CJ, Basavaraju SV. A comparison of transfusion-related adverse reactions among apheresis platelets, whole blood-derived platelets, and platelets subjected to pathogen reduction technology as reported to the national healthcare safety network hemovigilance module. Transfus Med Rev. 2021;35(2):78–84. doi:10.1016/j.tmrv.2021.03.003.
   PubMed Web of Science ®Google Scholar